InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Thomas Stephen Basil. Officer active across 2 companies, notably Eliem Therapeutics, Inc.. In total, 3 disclosures have been published. Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations